US 12257263
Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
granted A61KA61K31/65A61K31/7048
Quick answer
US patent 12257263 (Pharmaceutical compositions for demodex related blepharitis and eyelid crusting) held by Tarsus Pharmaceuticals, Inc. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tarsus Pharmaceuticals, Inc.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/65, A61K31/7048, A61K45/06, A61K47/06